{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-043354","form_type":"8-K/A","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.695927+00:00","generated_at":"2026-05-21T07:57:55.913972+00:00","sec_items":["3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ABVC BioPharma raises ~$619k via unregistered share sales to non-U.S. persons","bullets":["On April 30, 2025 sold 724,372 shares for ~$436k to 15 non-U.S. persons under Regulation S.","Additional subscriptions from May 9-13, 2025: 306,041 shares for ~$183,625 from 7 non-U.S. persons.","Each investor transferred voting rights to chairman Eugene Jiang via Voting Rights Proxy Agreement.","Shares are unregistered, restricted for one year, and sold without general solicitation.","Total gross proceeds from both tranches approximate $619,625."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-043354","json":"https://secwatch.observer/filing/0001213900-25-043354.json","markdown":"https://secwatch.observer/filing/0001213900-25-043354.md","text":"https://secwatch.observer/filing/0001213900-25-043354.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390025043354/0001213900-25-043354-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390025043354/ea0241575-8ka_abvcbio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T07:57:55.913972+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}